BioSpace News Archive

Replaces Retiring Art Sponseller in October

On Friday, August 17, the Biotechnology Innovation Organization (BIO) urged the Environmental Protection Agency (EPA) to use its authority under the Renewable Fuel Standard (RFS) program to strengthen America’s biobased economy.

Strava, the social network for athletes, today announces its newest Gym & Studio Sync partner, MINDBODY (NASDAQ: MB), the world’s leading booking platform for fitness classes.

Addus HomeCare Corporation (Nasdaq: ADUS) (“Addus” or the “Company”), a provider of home care services, today announced the closing of an underwritten public offering of 2,100,000 shares of its common stock (“Common Stock”) at a public offering price of $59.00 per share.

With a legacy dating as far back as 1962, Columbia Winery has been a longtime member of the Seattle area community. Last weekend brought the 12th Annual Columbia Winery Charity Walk & Run, which has pushed the Woodinville winery over $1 million in donations accrued to support of uncompensated care for Seattle Children’s Hospital.

Tilray Canada Ltd. (“Tilray”), a wholly owned subsidiary of Tilray, Inc. (Nasdaq: TLRY) announced today that the company has signed an agreement with the Ontario Cannabis Retail Corporation (“OCRC”), operating as the Cannabis Retail Store (“OCS”) to supply the province of Ontario with a diverse array of cannabis products in anticipation of the launch of the adult-use market on October 17, 2018.

NasalGuard®, a revolutionary drug-free topical gel that reduces the inhalation of harmful airborne contaminants announces an official rebrand and product debut just in time for summer travel, heat, colds, allergies, smog and other issues associated with air.

Partnership will provide free hormonal IUDs to underserved women across the country

Health Canada is advising Canadians that, as a precautionary measure, Teva Canada is expanding its voluntary recall to include eight additional lots of valsartan products in Canada because they may contain an impurity, N-nitrosodimethylamine (NDMA).

OncoTracker, Inc. announced the appointment of James Kuo, MD, MBA, as its Chief Executive Officer. Dr. Kuo is a biotech executive with more than 20 years of experience in corporate development, finance and licensing.